References
- Giovannucci E. Modifiable risk factors for colon cancer. Gastroenterol Clin North Am. 2002;31(4):925-43; DOI:10.1016/S0889-8553(02)00057-2.
- Labianca R, Beretta GD, Kildani B, Milesi L, Merlin F, Mosconi S, Pessi MA, Prochilo T, Quadri A, Gatta G, de Braud F, Wils J. Colon cancer. Crit Rev Oncol Hematol. 2010;74(2):106-33; DOI:10.1016/j. critrevonc.2010.01.010.
- Zamboni M, Rossi AP, Fantin F, Zamboni G, Chirumbolo S, Zoico E, Mazzali G. Adipose tissue, diet and aging. Mech Ageing Dev. 2014;136-137:129-37; DOI:10.1016/j.mad.2013.11.008.
- Duraiyarasan S, Adefuye M, Manjunatha N, Ganduri V, Rajasekaran K. Colon cancer and obesity: a narrative review. Cureus. 2022;14(8):e27589; DOI:10.7759/cureus.27589.
- Kaisanlahti A, Glumoff T. Browning of white fat: agents and implications for beige adipose tissue to type 2 diabetes. J Physiol Biochem. 2018;75(1):1-10; DOI:10.1007/s13105-018-0658-5.
- Heinonen S, Jokinen R, Rissanen A, Pietiläinen KH. White adipose tissue mitochondrial metabolism in health and in obesity. Obes Rev. 2019;21(2):e12958; DOI:10.1111/obr.12958.
- Lidell ME, Betz MJ, Enerbäck S. Brown adipose tissue and its therapeutic potential. J Intern Med. 2014;276(4):364-77; DOI:10.1111/joim.12255.
- Saely CH, Geiger K, Drexel H. Brown versus white adipose tissue: a mini-review. Gerontology. 2010;58(1):15-23; DOI:10.1159/000321319.
- Schwartz B, Yehuda-Shnaidman E. Putative Role of adipose tissue in growth and metabolism of colon cancer cells. Front Oncol. 2014;4:164; DOI:10.3389/fonc.2014.00164.
- Clemente-Suárez VJ, Redondo-Flórez L, Beltrán-Velasco AI, Martín-Rodríguez A, Martínez-Guardado I, Navarro-Jiménez E, Laborde-Cárdenas CC, Tornero-Aguilera JF. The role of adipokines in health and disease. Biomedicines. 2023;11(5):1290; DOI:10.3390/biomedicines11051290.
- Pham D, Park P. Tumor Metabolic reprogramming by adipokines as a critical driver of obesity-associated cancer progression. IJMS. 2021;22(3):1444; DOI:10.3390/ijms22031444.
- Kim JW, Kim JH, Lee YJ. The Role of adipokines in tumor progrespsion and its association with obesity. Biomedicines. 2024;12(1):97; DOI:10.3390/biomedicines12010097.
- Obradovic M, Sudar-Milovanovic E, Soskic S, Essack M, Arya S, Stewart AJ, Gojobori T, Isenovic ER. Leptin and obesity: role and clinical implication. Front Endocrinol. 2021;12: 585887; DOI:10.3389/fendo.2021.585887.
- Guo S, Liu M, Wang G, Torroella-Kouri M, Gonzalez-Perez RR. Oncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cells. Biochim Biophys Acta. 2012;1825(2):207-22; DOI:10.1016/j.bbcan.2012.01.002.
- Olea-Flores M, Juárez-Cruz JC, Zuñiga-Eulogio MD, Acosta E, García-Rodríguez E, Zacapala-Gomez AE, Mendoza-Catalán MA, Ortiz-Ortiz J, Ortuño-Pineda C, Navarro-Tito N. New actors driving the epithelial-mesenchymal transition in cancer: the role of leptin. Biomolecules. 2020;10(12):1676; DOI:10.3390/biom10121676.
- Ayed K, Nabi L, Akrout R, Mrizak H, Gorrab A, Bacha D, Boussen H, Gati A. Obesity and cancer: focus on leptin. Mol Biol Rep. 2023;50(7):6177-89; DOI:10.1007/s11033-023-08525-y.
- Jiménez-Cortegana C, López-Saavedra A, Sánchez-Jiménez F, Pérez-Pérez A, Castiñeiras J, Virizuela-Echaburu JA, de la Cruz-Merino LDL, Sánchez-Margalet V. Leptin, both bad and good actor in cancer. Biomolecules. 2021;11(6):913; DOI:10.3390/biom11060913.
- Khoramipour K, Chamari K, Hekmatikar AA, Ziyaiyan A, Taherkhani S, Elguindy NM, Bragazzi NL. Adiponectin: structure, physiological functions, role in diseases, and effects of nutrition. Nutrients. 2021;13(4):1180; DOI:10.3390/nu13041180.
- Oh DK, Ciaraldi T, Henry RR. Adiponectin in health and disease. Diabetes Obes Metab. 2006;9(3):282-9; DOI:10.1111/j.1463-1326.2006.00610.x.
- Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev. 2005;26(3):439-51; DOI:10.1210/er.2005-0005.
- Dalamaga M, Diakopoulos KN, Mantzoros CS. The role of adiponectin in cancer: a review of current evidence. Endocr Rev. 2012;33(4):547-94; DOI:10.1210/er.2011-1015.
- VanSaun MN. Molecular pathways: adiponectin and leptin signaling in cancer. Clin Cancer Res. 2013;19(8):1926-32; DOI:10.1158/1078-0432. CCR-12-0930.
- Kelesidis I, Kelesidis T, Mantzoros CS. Adiponectin and cancer: a systematic review. Br J Cancer. 2006;94(9):1221-5; DOI:10.1038/ sj.bjc.6603051.
- Booth A, Magnuson A, Fouts J, Foster M. Adipose tissue, obesity and adipokines: role in cancer promotion. Horm Mol Biol Clin Investig. 2015;21(1):57-74; DOI:10.1515/hmbci-2014-0037.
- Denzel MS, Hebbard LW, Shostak G, Shapiro L, Cardiff RD, Ranscht B. Adiponectin deficiency limits tumor vascularization in the MMTV-PyV-mT mouse model of mammary cancer. Clin Cancer Res. 2009;15(10):3256-64; DOI:10.1158/1078-0432.CCR-08-2661.
- Jia Z, Liu Y, Cui S. Adiponectin induces breast cancer cell migration and growth factor expression. Cell Biochem Biophys. 2014;70(2):1239-45; DOI:10.1007/s12013-014-0047-9.
- Falk Libby E, Liu J, Li YI, Lewis MJ, Demark-Wahnefried W, Hurst DR. Globular adiponectin enhances invasion in human breast cancer cells. Oncol Lett. 2016;11(1):633-41; DOI:10.3892/ol.2015.3965.
- Wang C, Wang P, Hsieh Y, Lo S, Lee Y, Chen Y, Tsai C, Chiu W, Chu-Sung Hu S, Lu C, Yang Y, Chiu C, Ou-Yang F, Wang Y, Hou M, Yuan S. Resistin facilitates breast cancer progression via TLR4-mediated induction of mesenchymal phenotypes and stemness properties. Oncogene. 2017;37(5):589-600; DOI:10.1038/onc.2017.357.
- Masoumi J, Jafarzadeh A, Khorramdelazad H, Abbasloui M, Abdolalizadeh J, Jamali N. Role of Apelin/APJ axis in cancer development and progression. Adv Med Sci. 2020;65(1):202-13; DOI:10.1016/j. advms.2020.02.002.
- Treeck O, Buechler C, Ortmann O. Chemerin and Cancer. IJMS. 2019;20(15):3750; DOI:10.3390/ijms20153750.
- Lin T. The role of visfatin in cancer proliferation, angiogenesis, metastasis, drug resistance and clinical prognosis. Cancer Manag Res. 2019;23:11:3481-91; DOI:10.2147/CMAR.S199597.
- Lee H, Lee IS, Choue R. Obesity, inflammation and diet. Pediatr Gastroenterol Hepatol Nutr. 2013;16(3):143; DOI:10.5223/pghn.2013.16.3.143.
- Ellulu MS, Patimah I, Khaza’ai H, Rahmat A, Abed Y. Obesity and inflammation: the linking mechanism and the complications. aoms. 2017;13(4):851-63; DOI:10.5114/aoms.2016.58928.
- Fletcher R, Wang Y, Schoen RE, Finn OJ, Yu J, Zhang L. Colorectal cancer prevention: immune modulation taking the stage. Biochim Biophys Acta Rev Cancer. 2018;1869(2):138-48; DOI:10.1016/j.bbcan.2017.12.002.
- Li X, Larsson P, Ljuslinder I, Öhlund D, Myte R, Löfgren-Burström A, Zingmark C, Ling A, Edin S, Palmqvist R. Ex vivo organoid cultures reveal the importance of the tumor microenvironment for maintenance of colorectal cancer stem cells. Cancers. 2020;12(4):923; DOI:10.3390/ cancers12040923.
- Taniguchi K, Karin M. IL-6 and related cytokines as the critical lynchpins between inflammation and cancer. Semin Immunol. 2014;26(1):54-74; DOI:10.1016/j.smim.2014.01.001.
- Rasic I, Rebic V, Rasic A, Aksamija G, Radovic S. The association of simultaneous increase in interleukin-6, C reactive protein, and matrix metal-loproteinase-9 serum levels with increasing stages of colorectal cancer. J Oncol. 2018;2018:2830503; DOI:10.1155/2018/2830503.
- Yeh K, Li Y, Hsieh L, Lu C, Chou W, Liaw C, Tang R, Liao S. Analysis of the effect of serum interleukin-6 (IL-6) and soluble IL-6 receptor levels on survival of patients with colorectal cancer. Japanese Jpn J Clin Oncol. 2010;40(6):580-7; DOI:10.1093/jjco/hyq010.
- Thomsen M, Kersten C, Sorbye H, Skovlund E, Glimelius B, Pfeiffer P, Johansen J, Kure E, Ikdahl T, Tveit K, Christoffersen T, Guren T. Inter-leukin-6 and C-reactive protein as prognostic biomarkers in metastatic colorectal cancer. Oncotarget. 2016;7(46):75013-22; DOI:10.18632/ oncotarget.12601.
- Himbert C, Ose J, Lin T, Warby C, Gigic B, Steindorf K, Schrotz-king P, Abbenhardt-martin C, Zielske L, Boehm J, Ulrich C. Inflammation- and angiogenesis-related biomarkers are correlated with cancer-related fatigue in colorectal cancer patients: Results from the ColoCare Study. Eur J Cancer Care. 2019;28(4): e13055; DOI:10.1111/ecc.13055.
- Yu H, Lee H, Herrmann A, Buettner R, Jove R. Revisiting STAT3 signalling in cancer: new and unexpected biological functions. Nat Rev Cancer. 2014;14(11):736-46; DOI:10.1038/nrc3818.
- Johnson D, O’Keefe R, Grandis J. Targeting the IL-6/JAK/STAT3 signalling axis in cancer. Nat Rev Clin Oncol. 2018;15(4):234-48; DOI:10.1038/ nrclinonc.2018.8.
- Fan Y, Mao R, Yang J. NF-κB and STAT3 signaling pathways collaboratively link inflammation to cancer. Protein Cell. 2013;4(3):176-85; DOI:10.1007/s13238-013-2084-3.
- Fain J. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam Horm. 2006;74:443-77; DOI:10.1016/ S0083-6729(06)74018-3.
- Baumgart D, Sandborn W. Inflammatory bowel disease: clinical aspects and established and evolving therapies.. Lancet. 2007;369(9573):1641-57; DOI:10.1016/S0140-6736(07)60751-X.
- Wei X, Li X, Kong F, Ma L, Sui Y, Chen D, Xu F. TNF-α activates Wnt signaling pathway to promote the invasion of human colon cancer stem cells. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2018;34(11):982-8.
- Kern L, Mittenbühler M, Vesting A, Ostermann A, Wunderlich C, Wunderlich F. Obesity-induced TNFα and IL-6 signaling: the missing link between obesity and inflammation-driven liver and colorectal cancers. Cancers (Basel). 2018;11(1):24; DOI:10.3390/cancers11010024.
- Landskron G, De M, Thuwajit P, Thuwajit C, Hermoso M. Chronic inflammation and cytokines in the tumor microenvironment. J Immunol Res. 2014;2014():149185; DOI:10.1155/2014/149185.
- Al O, Alkhayal K, Al A, Zubaidi A, Vaali-mohammed M, Boushey R, Mckerrow J, Abdulla M. Increased expression of tumor necrosis factor-α is associated with advanced colorectal cancer stages. World J Gastroenterol. 2014;20(48):18390-6; DOI:10.3748/wjg.v20.i48.18390.
- Borowczak J, Szczerbowski K, Maniewski M, Kowalewski A, Janiczek-polewska M, Szylberg A, Marszałek A, Szylberg Ł. The Role of Inflammatory cytokines in the pathogenesis of colorectal carcinoma-recent findings and review. Biomedicines. 2022;10(7):1670; DOI:10.3390/biomedicines10071670.
- Grivennikov S, Karin M. Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer. Cytokine Growth Factor Rev. 2010;21(1):11-9; DOI:10.1016/j.cytogfr.2009.11.005.
- WHO. Obesity: preventing and managing the global epidemic: report of a WHO consultation. Geneva: World Health Organization; 2000. 253 p. Report No.:894.
- WHO. Obesity and overweight [Internet]. Geneva: World Health Organization; 2024 [cited 2024 Sep 05]. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight/.
- Safaei M, Sundararajan E, Driss M, Boulila W, Shapi’i A. A systematic literature review on obesity: understanding the causes & consequences of obesity and reviewing various machine learning approaches used to predict obesity. Comput Biol Med. 2021;136:104754; DOI:10.1016/j. compbiomed.2021.104754.
- Poirier P, Giles T, Bray G, Hong Y, Stern J, Pi-sunyer F, Eckel R, American A, Obesity M. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2006;113(6):898-918; DOI:10.1161/ CIRCULATIONAHA.106.171016.
- Gallagher E, Leroith D. Obesity and Diabetes: the increased risk of cancer and cancer-related Mortality. Physiol Rev. 2015;95(3):727-48; DOI:10.1152/physrev.00030.2014.
- Renehan A, Tyson M, Egger M, Heller R, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371(9612):569-78; DOI:10.1016/S0140-6736(08)60269-X.
- Jenabi E, Poorolajal J. The effect of body mass index on endometrial cancer: a meta-analysis.. Public Health. 2015;129(7):872-0; DOI:10.1016/j. puhe.2015.04.017.
- Hoyo C, Cook M, Kamangar F, Freedman N, Whiteman D, Bernstein L, Brown L, Risch H, Ye W, Sharp L, Wu A, Ward M, Casson A, Murray L, Corley D, Nyrén O, Pandeya N, Vaughan T, Chow W, Gammon M. Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium. Int J Epidemiol. 2012;41(6):1706-8; DOI:10.1093/ije/dys176.
- Chen Y, Liu L, Wang X, Wang J, Yan Z, Cheng J, Gong G, Li G. Body mass index and risk of gastric cancer: a meta-analysis of a population with more than ten million from 24 prospective studies. Cancer Epidemiol Biomarkers Prev. 2013;22(8):1395-408; DOI:10.1158/1055-9965. EPI-13-0042.
- Genkinger J, Spiegelman D, Anderson K, Bernstein L, Van P, Calle E, English D, Folsom A, Freudenheim J, Fuchs C, Giles G, Giovannucci E, Horn-ross P, Larsson S, Leitzmann M, Männistö S, Marshall J, Miller A, Patel A, Rohan T, Stolzenberg-solomon R, Verhage B, Virtamo J, Willcox B, Wolk A, Ziegler R, Smith-warner S. A pooled analysis of 14 cohort studies of anthropometric factors and pancreatic cancer risk. Int J Cancer. 2011;129(7):1708-17; DOI:10.1002/ijc.25794.
- Ma Y, Yang Y, Wang F, Zhang P, Shi C, Zou Y, Qin H. Obesity and risk of colorectal cancer: a systematic review of prospective studies. PLoS One. 2013;8(1):e53916; DOI:10.1371/journal.pone.0053916.
- Li L, Gan Y, Li W, Wu C, Lu Z. Overweight, obesity and the risk of gallbladder and extrahepatic bile duct cancers: a meta-analysis of observational studies. Obesity (Silver Spring). 2016;24(8):1786-802; DOI:10.1002/ oby.21505.
- Coe P, O’reilly D, Renehan A. Excess adiposity and gastrointestinal cancer. Br J Surg. 2014;101(12):1518-31;discussion 1531; DOI:10.1002/ bjs.9623.
- Munsell M, Sprague B, Berry D, Chisholm G, Trentham-dietz A. Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status.. Epidemiol Rev. 2014;36(1):114-36; DOI:10.1093/epirev/mxt010.
- Chan DSM, Abar L, Cariolou M, Nanu N, Greenwood DC, Bandera EV, Mctiernan A, Norat T. World Cancer Research Fund International: continuous update project-systematic literature review and meta-analysis of observational cohort studies on physical activity, sedentary behavior, adiposity, and weight change and breast cancer risk. Cancer Causes Control. 2019;30(11):1183-200; DOI:10.1007/s10552-019-01223-w.
- IARC. World Cancer Report [Internet]. Geneva: World Health Organization; 2020 [cited 2024 Sep 05]. Available from: https://www.iarc.who.int/cards_page/world-cancer-report/.
- Lauby-secretan B, Scoccianti C, Loomis D, Grosse Y, Bianchini F, Straif K, International G. Body fatness and cancer – viewpoint of the IARC working group. N Engl J Med. 2016;375(8):794-8; DOI:10.1056/ NEJMsr1606602.
- Kyrgiou M, Kalliala I, Markozannes G, Gunter MJ, Paraskevaidis E, Gabra H, Martin-hirsch P, Tsilidis K. Adiposity and cancer at major anatomical sites: umbrella review of the literature. BMJ. 2017;356:j477; DOI:10.1136/bmj.j477.
- Gibson TM, Park Y, Robien K, Shiels MS, Black A, Sampson JN, Purdue MP, Freeman LE, Andreotti G, Weinstein SJ, Albanes D, Fraumeni JF, Curtis RE, de Gonzalez AB, Morton LM. Body mass index and risk of second obesity-associated cancers after colorectal cancer: a pooled analysis of prospective cohort studies. J Clin Oncol. 2014;32(35):4004-11; DOI:10.1200/JCO.2014.56.8444.
- Ibrahim MM. Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Re. 2009;11(1):11-8; DOI:10.1111/j.1467-789x.2009.00623.x.
- Sears B, Perry M. The role of fatty acids in insulin resistance. Lipids Health Dis. 2015;14:121; DOI:10.1186/s12944-015-0123-1.
- Galic S, Oakhill JS, Steinberg GR. Adipose tissue as an endocrine organ. Mol Cell Endocrinol. 2010;316(2):129-39; DOI:10.1016/j. mce.2009.08.018.
- Bensussen A, Torres-Magallanes JA, Roces de Alvarez-Buylla E. Molecular tracking of insulin resistance and inflammation development on visceral adipose tissue. Front. Immunol.. 2023;14: 1014778; DOI:10.3389/fimmu.2023.1014778.
- Matsuzawa Y, Shimomura I, Nakamura T, Keno Y, Kotani K, Tokunaga K. Pathophysiology and pathogenesis of visceral fat obesity. Obes Res. 1995;3(Suppl 2): 187S-94S; DOI:10.1002/j.1550-8528.1995.tb00462.x.
- Dhokte S, Czaja K. Visceral adipose tissue: the hidden culprit for type 2 diabetes. Nutrients. 2024;16(7):1015; DOI:10.3390/nu16071015.
- Gyamfi D, Awuah EO, Owusu S. Molecular aspects and biochemical regulation of diabetes mellitus. In: Patel VB, editor. Molecular nutrition: carbohydrates. Amsterdam: Elsevier; 2019. Chapter 3.
- Shukla A, Grisouard J, Ehemann V, Hermani A, Enzmann H, Mayer D. Analysis of signaling pathways related to cell proliferation stimulated by insulin analogs in human mammary epithelial cell lines. Endocr Relat Cancer. 2009;16(2):429-41; DOI:10.1677/erc-08-0240.
- Szablewski L. Insulin resistance: the increased risk of cancers. Curr Oncol. 2024;31(2):998-1027; DOI:10.3390/curroncol31020075.
- Doyle SL, Donohoe CL, Lysaght J, Reynolds JV. Visceral obesity, metabolic syndrome, insulin resistance and cancer. Proc Nutr Soc. 2011;71(1):181-9; DOI:10.1017/s002966511100320x.
- Gligorijević N, Dobrijević Z, Šunderić M, Robajac D, Četić D, Penezić A, Miljuš G, Nedić O. The insulin-like growth factor system and colorectal cancer. Life (Basel). 2022;12(8):1274; DOI:10.3390/life12081274.
- Arcidiacono B, Iiritano S, Nocera A, Possidente K, Nevolo MT, Ventura V, Foti D, Chiefari E, Brunetti A. Insulin resistance and cancer risk: an overview of the pathogenetic mechanisms. Exp Diabetes Res. 2012;2012:789174; DOI:10.1155/2012/789174.
- Ma J, Pollak MN, Giovannucci E, Chan JM, Tao Y, Hennekens CH, Stampfer MJ. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst. 1999;91(7):620-5; DOI:10.1093/jnci/91.7.620.
- Shin AE, Giancotti F, Rustgi A. Metastatic colorectal cancer: mechanisms and emerging therapeutics. Trends Pharmacol Sci. 2023;44(4):222-36; DOI:10.1016/j.tips.2023.01.003.
- Xiao Y, Yu D. Tumor microenvironment as a therapeutic target in cancer. Pharmacol Ther. 2021;221:107753; DOI:10.1016/j. pharmthera.2020.107753.
- Jin M-Z, Jin W-L. The updated landscape of tumor microenvironment and drug repurposing. Signal Transduct Target Ther. 2020;5(1):166; DOI:10.1038/s41392-020-00280-x.
- Chaplin A, Rodriguez RM, Segura-Sampedro JJ, Ochogavía-Seguí A, Romaguera D, Barceló-Coblijn G. Insights behind the relationship between colorectal cancer and obesity: is visceral adipose tissue the missing link? Int J Mol Sci. 2022;23(21):13128; DOI:10.3390/ijms232113128.
- Yao H, He S. Multi-faceted role of cancer-associated adipocytes in the tumor microenvironment (Review). Mol Med Rep. 2021;24(6):866; DOI:10.3892/mmr.2021.12506.
- Wu Q, Li B, Li J, Sun S, Yuan J, Sun S. Cancer-associated adipocytes as immunomodulators in cancer. Biomark Res. 2021;9(1):2; DOI:10.1186/ s40364-020-00257-6.
- Lo Iacono M, Modica C, Porcelli G, Brancato OR, Muratore G, Bianca P, Gaggianesi M, Turdo A, Veschi V, Todaro M, Di Franco S, Stassi G. Targeting of the Peritumoral Adipose Tissue Microenvironment as an Innovative Antitumor Therapeutic Strategy. Biomolecules. 2022;12(5):702; DOI:10.3390/biom12050702.
- Dirat B, Bochet L, Dabek M, Daviaud D, Dauvillier S, Majed B, Wang YY, Meulle A, Salles B, Le Gonidec S, Garrido I, Escourrou G, Valet P, Muller C. Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion. Cancer Res. 2011;71(7):2455-65; DOI:10.1158/0008-5472.CAN-10-3323.
- Zoico E, Rizzatti V, Darra E, Budui SL, Franceschetti G, Vinante F, Pedrazzani C, Guglielmi A, De Manzoni G, Mazzali G, Rossi AP, Fantin F, Zamboni M. Morphological and functional changes in the peritumoral adipose tissue of colorectal cancer patients. Obesity (Silver Spring). 2017;25 (Suppl 2):S87-94; DOI:10.1002/oby.22008.
- Wen Y, Xing X, Harris J, Zaytseva Y, Mitov M, Napier D, Weiss H, Mark B, Gao T. Adipocytes activate mitochondrial fatty acid oxidation and autophagy to promote tumor growth in colon cancer. Cell Death Dis. 2017;8(2):e2593; DOI:10.1038/cddis.2017.21.
- Wang YY, Attane C, Milhas D, Dirat B, Dauvillier S, Guerard A, Gilhodes J, Lazar I, Alet N, Laurent V, Le Gonidec S, Biard D, Hervé C, Bost F, Ren GS, Bono F, Escourrou G, Prentki M, Nieto L, Valet P, Muller C. Mammary adipocytes stimulate breast cancer invasion through metabolic remodeling of tumor cells. JCI Insight. 2017;2(4):e87489; DOI:10.1172/jci. insight.87489.
- Wu Q, Li B, Li Z, Li J, Sun S, Sun S. Cancer-associated adipocytes: key players in breast cancer progression. J Hematol Oncol. 2019;12(1):95; DOI:10.1186/s13045-019-0778-6.
- Kasprzak A. The role of tumor microenvironment cells in colorectal cancer (CRC) Cachexia. Int J Mol Sci. 2021;22(4):1565; DOI:10.3390/ ijms22041565.
- Arneth B. Tumor microenvironment. medicina (Kaunas). 2019;56(1):15; DOI:10.3390/medicina56010015.
- Wu X, Cai J, Zuo Z, Li J. Collagen facilitates the colorectal cancer stemness and metastasis through an integrin/PI3K/AKT/Snail signaling pathway. Biomed Pharmacother. 2019;114:108708; DOI:10.1016/j. biopha.2019.108708.
- Ma Y, Nenkov M, Chen Y, Gaßler N. The role of adipocytes recruited as part of tumor microenvironment in promoting colorectal cancer metastases. Int J Mol Sci. 2024;25(15):; DOI:10.3390/ijms25158352.
- Gong J, Lin Y, Zhang H, Liu C, Cheng Z, Yang X, Zhang J, Xiao Y, Sang N, Qian X, Wang L, Cen X, Du X, Zhao Y. Reprogramming of lipid metabolism in cancer-associated fibroblasts potentiates migration of colorectal cancer cells. Cell Death Dis. 2020;11(4):267; DOI:10.1038/ s41419-020-2434-z.
- Thanikachalam K, Khan G. Colorectal cancer and nutrition. Nutrients. 2019;11(1):164; DOI:10.3390/nu11010164.
- Liu L, Shi Y, Li T, Qin Q, Yin J, Pang S, Nie S, Wei S. Leisure time physical activity and cancer risk: evaluation of the WHO’s recommendation based on 126 high-quality epidemiological studies. Br J Sports Med. 2016;50(6):372-8; DOI:10.1136/bjsports-2015-094728.
- Song M, Wu K, Meyerhardt JA, Ogino S, Wang M, Fuchs CS, Giovannucci EL, Chan AT. Fiber intake and survival after colorectal cancer diagnosis. JAMA Oncol. 2018;4(1):71-9; DOI:10.1001/jamaoncol.2017.3684.
- McCullough ML, Zoltick ES, Weinstein SJ, Fedirko V, Wang M, Cook NR, Eliassen AH, Zeleniuch-Jacquotte A, Agnoli C, Albanes D, Barnett MJ, Buring JE, Campbell PT, Clendenen TV, Freedman ND, Gapstur SM, Giovannucci EL, Goodman GG, Haiman CA, Ho GYF, Horst RL, Hou T, Huang WY, Jenab M, Jones ME, Joshu CE, Krogh V, Lee IM, Lee JE, Männistö S, Le Marchand L, Mondul AM, Neuhouser ML, Platz EA, Purdue MP, Riboli E, Robsahm TE, Rohan TE, Sasazuki S, Schoemaker MJ, Sieri S, Stampfer MJ, Swerdlow AJ, Thomson CA, Tretli S, Tsugane S, Ursin G, Visvanathan K, White KK, Wu K, Yaun SS, Zhang X, Willett WC, Gail MH, Ziegler RG, Smith-Warner SA. Circulating vitamin D and colorectal cancer risk: an international pooling project of 17 cohorts. J Natl Cancer Inst. 2019;111(2):158-69; DOI:10.1093/jnci/djy087.
- Cai S, Li Y, Ding Y, Chen K, Jin M. Alcohol drinking and the risk of colorectal cancer death: a meta-analysis. Eur J Cancer Prev. 2014;23(6):532-9; DOI:10.1097/CEJ.0000000000000076.
- Dashti SG, Buchanan DD, Jayasekara H, Ait Ouakrim D, Clendenning M, Rosty C, Winship IM, Macrae FA, Giles GG, Parry S, Casey G, Haile RW, Gallinger S, Le Marchand L, Thibodeau SN, Lindor NM, Newcomb PA, Potter JD, Baron JA, Hopper JL, Jenkins MA, Win AK. Alcohol Consumption and the Risk of Colorectal Cancer for Mismatch Repair Gene Mutation Carriers. Cancer Epidemiol Biomarkers Prev. 2017;26(3):366-75; DOI:10.1158/1055-9965.EPI-16-0496.
- Mizumoto A, Ohashi S, Hirohashi K, Amanuma Y, Matsuda T, Muto M. Molecular Mechanisms of Acetaldehyde-Mediated Carcinogenesis in Squamous Epithelium. Int J Mol Sci. 2017;18(9):1943; DOI:10.3390/ijms18091943.
- Roncucci L, Mariani F. Prevention of colorectal cancer: how many tools do we have in our basket? Eur J Intern Med. 2015;26(10):752-6; DOI:10.1016/j.ejim.2015.08.019.
- Himbert C, Ose J, Gigic B, Viskochil R, Santuci K, Lin T, Ashworth A, Cohan JN, Scaife CL, Jedrzkiewicz J, Damerell V, Atkins KM, Gong J, Mutch MG, Bernadt C, Felder S, Sanchez J, Cohen SA, Krane MK, Hinkle N, Wood E, Peoples AR, Figueiredo JC, Toriola AT, Siegel EM, Li CI, Shibata D, Boucher K, Round JL, Ulrich AB, Schneider M, Huang LC, Hardikar S, Ulrich CM. Associations of combined physical activity and body mass index groups with colorectal cancer survival outcomes. BMC Cancer. 2023;23(1):300; DOI:10.1186/s12885-023-10695-8.
- Boido A, Ceriani V, Cetta F, Lombardi F, Pontiroli AE. Bariatric surgery and prevention of cardiovascular events and mortality in morbid obesity: mechanisms of action and choice of surgery. Nutr Metab Cardiovasc Dis. 2015;25(5):437-43; DOI:10.1016/j.numecd.2015.01.011.
- Miranda BCJ, Tustumi F, Nakamura ET, Shimanoe VH, Kikawa D, Waisberg J. Obesity and Colorectal Cancer: A Narrative Review. Medicina (Kaunas). 2024;60(8):1218; DOI:10.3390/medicina60081218.